23.03.2010 • News

Expansion of Basic Chemicals Facilities at Lanxess on Schedule

In the coming weeks, the capacity expansion program for chlorotoluenes, cresols and their derivatives that Lanxess announced in late October 2008 will reach completion, the company has reported. The specialty chemicals company said it will then have up to 60% higher capacities for these important basic chemicals for the global market. In total, the Basic Chemicals business unit (BAC) will have invested around €35 million in this network of facilities in Leverkusen.

"Despite the economic downturn, we've continued to move forward with the project because a major percentage of this expansion in volume is supported by contractual agreements," says Dr. Hans-Georg Schmitt, head of BAC.

The expansion program, which is nearing completion, also includes plans to increase the manufacture of menthol. In collaboration with Symrise, a project has been launched to significantly extend menthol capacities. Dr. Norbert Richter, senior vice president of the Aroma Molecules Business Unit of Symrise, a fragrance and flavoring manufacturer, welcomes the availability of higher capacities at Lanxess for manufacturing this precursor: "Symrise produces menthol using raw materials from Lanxess. Reliable supply is of critical importance to us, because menthol is a key component in many aromas for the oral hygiene and chewing gum segments. It further is used in a variety of pharmaceutical products."

Company

Logo:

LANXESS Deutschland GmbH

Kennedyplatz 1
50569 Köln
Germany

Company contact







Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read